The HRP-conjugated SESN2 antibody typically combines a primary antibody specific to SESN2 with the HRP enzyme. This conjugation eliminates the need for secondary antibodies in detection workflows, streamlining assays. For example:
Target Specificity: The antibody binds to SESN2 epitopes, such as those in the EPR18907 clone (aa 1–250), with high affinity .
Enzymatic Activity: HRP catalyzes substrate reactions (e.g., luminol for chemiluminescence) to generate detectable signals proportional to SESN2 levels .
Studies using SESN2 antibodies (non-HRP primary + HRP-secondary) demonstrate:
Efficiency: SESN2 antibodies effectively immunoprecipitate SESN2 from HeLa lysates, as shown by clean band isolation and minimal background in IP-Western blots .
Buffer Compatibility: Works in 5% NFDM/TBST blocking buffer with 1:1000 dilution .
SESN2 upregulation in osteosarcoma cells reduces apoptosis and confers resistance to chemotherapeutic agents (cisplatin, doxorubicin) .
Mechanism: SESN2 knockdown increases cleaved PARP (apoptosis marker) and reduces LC3-II/LC3-I ratios (autophagy marker), sensitizing cells to drugs .
SESN2 inhibits RIPK3-mediated necroptosis by blocking RIPK3 phosphorylation and necrosome formation .
Consequence: SESN2 deficiency exacerbates inflammation and oxidative stress in metabolic dysfunction-associated steatohepatitis (MASH) .
Cross-Reactivity: No observed cross-reactivity with SESN1 or SESN3 in validated models .
Storage: Stable in PBS with 0.02% sodium azide; avoid freeze-thaw cycles .
Most studies use non-conjugated SESN2 antibodies paired with HRP-secondary reagents . Direct HRP-conjugated SESN2 antibodies remain less documented, suggesting a niche for method optimization.
In vivo applications (e.g., animal models) require further validation of HRP-conjugated formats for tissue-specific detection .
SESN2 (Sestrin2) is a stress-inducible metabolic regulator that responds to diverse cellular stresses. It plays critical roles in:
SESN2 is widely expressed across multiple tissues and primarily localized in the cytoplasm, with a canonical protein length of 480 amino acid residues and a mass of approximately 54.5 kDa . Its involvement in multiple stress response pathways makes it a valuable target for researchers studying cellular stress, metabolism, and disease states.
When using SESN2 antibodies in Western blot applications, researchers should expect:
The canonical molecular weight of 54-60 kDa for the full-length protein
Potential variations in observed weights (54-60 kDa range) depending on post-translational modifications
In some cellular stress conditions, alternative bands may be observed
This information is critical for proper identification of SESN2 in experimental samples. Always include positive controls such as HEK-293, HeLa, or K-562 cell lysates, which have been confirmed to express detectable levels of SESN2 .
For optimal Western blot results with HRP-conjugated SESN2 antibodies:
When studying SESN2 interactions with binding partners like IGF2BP3 or HK2 mRNA, extended exposure times may be necessary to detect complex formation . For stress-induced upregulation experiments, ensure adequate sample collection time points as SESN2 expression increases substantially after 12 hours of LPS stimulation .
Rigorous validation of SESN2 antibodies is essential to ensure experimental reliability:
Genetic controls: Use SESN2 knockout (Sesn2^-/-) samples as negative controls
Overexpression controls: Include SESN2-overexpressing samples (e.g., cells transfected with plasmid carrying the SESN2 gene)
Peptide competition assay: Pre-incubate antibody with immunizing peptide to confirm specific binding
Cross-reactivity testing: Test across multiple species if working with non-human models
Multiple antibody validation: Compare results from antibodies targeting different epitopes of SESN2
Validation data should be documented and included in publications. For example, research has shown that SESN2 antibodies can reliably detect the induced expression in hepatocellular carcinoma (HCC) cells under glucose deprivation conditions and in macrophages after extended LPS stimulation .
SESN2 has been implicated in stress granule dynamics, particularly in relation to stabilizing hexokinase 2 (HK2) mRNA. To study this role:
Co-localization studies:
Use HRP-conjugated SESN2 antibodies alongside fluorescently-labeled stress granule markers (e.g., G3BP1)
Perform proximity ligation assays to visualize spatial relationships between SESN2 and stress granule components
RNA-protein interaction analysis:
Stress-induced dynamics:
These approaches can reveal how SESN2 contributes to stress granule formation and the fate of specific mRNAs during cellular stress responses.
When using SESN2 antibodies for chromatin immunoprecipitation (ChIP) studies:
Crosslinking optimization:
For SESN2-associated chromatin studies, use 1% formaldehyde for 10 minutes at room temperature
Double crosslinking with disuccinimidyl glutarate (DSG) followed by formaldehyde can improve detection of indirect DNA associations
Sonication parameters:
Optimize to achieve 200-500 bp DNA fragments
Verify fragment size by agarose gel electrophoresis
Antibody selection:
Controls:
Data analysis:
Normalize to input and IgG controls
Compare enrichment across different experimental conditions
This approach has revealed that SETDB1 accumulates on the SESN2 promoter and promotes recruitment of H3K9me3, leading to transcriptional repression .
When encountering multiple bands or unexpected molecular weights:
Post-translational modifications: SESN2 can undergo phosphorylation and ubiquitination , potentially altering migration patterns
Isoform detection: Verify which isoforms your antibody recognizes and whether tissue-specific variants exist
Degradation products: Fresh sample preparation and inclusion of protease inhibitors can minimize degradation
Cross-reactivity: Test specificity using:
Stress-induced modifications: Under certain stress conditions, SESN2 can form complexes that alter its migration pattern
To distinguish between specific and non-specific bands, researchers should compare results across multiple antibodies and validate with genetic approaches.
For investigating SESN2's role in mitophagy:
Mitochondrial fractionation studies:
Co-immunoprecipitation approaches:
Functional assays:
Mitophagy flux assessment:
These approaches can help elucidate how SESN2 contributes to mitochondrial quality control, particularly in contexts like inflammation where SESN2-mediated mitophagy protects against NLRP3 inflammasome hyperactivation .
When investigating SESN2's role in B cell immunology:
Detection of SESN2 in B cells:
Analyzing class switch recombination:
Promoter activity assays:
AMPK pathway investigation: